Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Use this KNSA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KNSA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KNSA SEC filings page. Lician reads the product cache first so this HTML stays unique to Kiniksa Pharmaceuticals Ltd even when a live quote feed is slow.
Latest cached year on this hub. Full KNSA income, balance, and cash tables.